Market Overview:
The global single cell multiomics market reached a value of US$ 2.85 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.73 Billion by 2027, exhibiting at a CAGR of 17.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Single cell multiomics refers to the analysis of multiple types of molecules from an individual cell to gain insights regarding cellular diversity and heterogenity. It involves single cell genomics, proteomics, transcriptomics and metabolomics and is widely used in neurology, immunology, cell biology and oncology. Single cell multiomics aids in enhancing the understanding of population architectures and cellular properties of heterogeneous tissues. It utilizes single cell isolation and dispensing techniques to provide images of the molecular layers and complex biological structures. In comparison to the traditionally used live-cell fluorescence imaging techniques, single-cell multi-omics does not involve the destruction of cells for analysis and can measure multiple types of the molecule from a single cell. As a result, it is widely used across biotechnology and pharmaceutical organizations, hospitals, academics and research institutes and diagnostic laboratories.
Single Cell Multiomics Market Trends:
The rising prevalence of chronic diseases, such as cancer and communicable viral diseases, is one of the key factors driving the growth of the market. Single cell multiomics provides a high-resolution landscape of cellular components in the tumors. Additionally, the widespread product adoption for visualization and analysis of cell heterogeneity, tumor micro-environment and antibody development are favoring the market growth. Moreover, various technological advancements, such as the development of single-cell isolation and barcoding technologies that enable deoxyribonucleic acid (DNA), messenger ribonucleic acid (mRNA) and protein profiles to be measured at a single-cell resolution, are providing a thrust to the market growth. In line with this, significant growth in the pharmaceutical industry is positively impacting the market growth. Other factors, including the increasing adoption of personalized medicine for the treatment of genetic disorders, along with the extensive improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global single cell multiomics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, product type, technique, application and end user.
Breakup by Type:
- Single Cell Genomics
- Single Cell Proteomics
- Single Cell Transcriptomics
- Single Cell Metabolomics
Breakup by Product Type:
- Consumables
- Instruments
- Software
Breakup by Technique:
- Single-Cell Isolation and Dispensing
- Single-Cell Analysis
Breakup by Application:
- Oncology
- Cell Biology
- Neurology
- Others
Breakup by End User:
- Academic Institutes
- Contract Research Organizations
- Pharmaceutical and Biotech Companies
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Type, Product Type, Technique, Application, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
10x Genomics Inc., Becton Dickinson and Company, BGI Genomics (BGI Group), Bio-RAD Laboratories Inc., Fluidigm Corporation, Illumina Inc., Mission Bio, NanoCellect Biomedical, Nanostring Technologies Inc., Proteona, Takara Bio Inc. (Takara Holdings) and Thermo Fisher Scientific Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global single cell multiomics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global single cell multiomics market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the technique?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global single cell multiomics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Single Cell Multiomics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Single Cell Genomics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Single Cell Proteomics
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Single Cell Transcriptomics
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Single Cell Metabolomics
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Product Type
7.1 Consumables
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Instruments
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Software
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Technique
8.1 Single-Cell Isolation and Dispensing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Single-Cell Analysis
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Application
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Cell Biology
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Neurology
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End User
10.1 Academic Institutes
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Contract Research Organizations
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Pharmaceutical and Biotech Companies
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 10x Genomics Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.2 Becton Dickinson and Company
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 BGI Genomics (BGI Group)
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Bio-RAD Laboratories Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Fluidigm Corporation
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.6 Illumina Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Mission Bio
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 NanoCellect Biomedical
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Nanostring Technologies Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 Proteona
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Takara Bio Inc. (Takara Holdings)
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 Thermo Fisher Scientific Inc.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Single Cell Multiomics Market: Major Drivers and Challenges
Figure 2: Global: Single Cell Multiomics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Single Cell Multiomics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Single Cell Multiomics Market: Breakup by Type (in %), 2021
Figure 5: Global: Single Cell Multiomics Market: Breakup by Product Type (in %), 2021
Figure 6: Global: Single Cell Multiomics Market: Breakup by Technique (in %), 2021
Figure 7: Global: Single Cell Multiomics Market: Breakup by Application (in %), 2021
Figure 8: Global: Single Cell Multiomics Market: Breakup by End User (in %), 2021
Figure 9: Global: Single Cell Multiomics Market: Breakup by Region (in %), 2021
Figure 10: Global: Single Cell Multiomics (Single Cell Genomics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Single Cell Multiomics (Single Cell Genomics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Single Cell Multiomics (Single Cell Proteomics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Single Cell Multiomics (Single Cell Proteomics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Single Cell Multiomics (Single Cell Transcriptomics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Single Cell Multiomics (Single Cell Transcriptomics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Single Cell Multiomics (Single Cell Metabolomics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Single Cell Multiomics (Single Cell Metabolomics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Single Cell Multiomics (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Single Cell Multiomics (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Single Cell Multiomics (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Single Cell Multiomics (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Single Cell Multiomics (Software) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Single Cell Multiomics (Software) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Single Cell Multiomics (Single-Cell Isolation and Dispensing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Single Cell Multiomics (Single-Cell Isolation and Dispensing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Single Cell Multiomics (Single-Cell Analysis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Single Cell Multiomics (Single-Cell Analysis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Single Cell Multiomics (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Single Cell Multiomics (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Single Cell Multiomics (Cell Biology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Single Cell Multiomics (Cell Biology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Single Cell Multiomics (Neurology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Single Cell Multiomics (Neurology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Single Cell Multiomics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Single Cell Multiomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Single Cell Multiomics (Academic Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Single Cell Multiomics (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Single Cell Multiomics (Contract Research Organizations) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Single Cell Multiomics (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Single Cell Multiomics (Pharmaceutical and Biotech Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Single Cell Multiomics (Pharmaceutical and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: North America: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: North America: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: United States: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: United States: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Canada: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Canada: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Asia-Pacific: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Asia-Pacific: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: China: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: China: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Japan: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Japan: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: India: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: India: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: South Korea: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: South Korea: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Australia: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Australia: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Indonesia: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Indonesia: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Europe: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Europe: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Germany: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Germany: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: France: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: France: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: United Kingdom: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: United Kingdom: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Italy: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Italy: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Spain: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Spain: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Russia: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Russia: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Others: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Others: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Latin America: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Latin America: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Brazil: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Brazil: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Mexico: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Mexico: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Others: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Others: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Middle East and Africa: Single Cell Multiomics Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Middle East and Africa: Single Cell Multiomics Market: Breakup by Country (in %), 2021
Figure 90: Middle East and Africa: Single Cell Multiomics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Global: Single Cell Multiomics Industry: SWOT Analysis
Figure 92: Global: Single Cell Multiomics Industry: Value Chain Analysis
Figure 93: Global: Single Cell Multiomics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Single Cell Multiomics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Single Cell Multiomics Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Single Cell Multiomics Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 4: Global: Single Cell Multiomics Market Forecast: Breakup by Technique (in Million US$), 2022-2027
Table 5: Global: Single Cell Multiomics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Single Cell Multiomics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 7: Global: Single Cell Multiomics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 8: Global: Single Cell Multiomics Market: Competitive Structure
Table 9: Global: Single Cell Multiomics Market: Key Players